Researchers at Mount Sinai and Memorial Sloan Kettering believe they’ve made a breakthrough in a new form of cancer treatment ...
Anthem Blue Cross Blue Shield and Memorial Sloan Kettering Cancer Center have reached a deal that keeps the premiere cancer ...
Long before mRNA vaccines captured global attention during the COVID-19 pandemic, researchers were already exploring their ...
NEW YORK--(BUSINESS WIRE)--Anthem Blue Cross and Blue Shield in New York and Memorial Sloan Kettering Cancer Center (MSK) announced today that the organizations have reached a new multi-year ...
The impasse comes as health insurance companies have faced heightened scrutiny following UnitedHealthcare CEO Brian ...
Researchers at The Tisch Cancer Institute at Mount Sinai, in collaboration with Memorial Sloan Kettering Cancer Center (MSK), ...
News Medical on MSN2d
AI-based SCORPIO tool offers better cancer immunotherapy predictionsDoctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors - a type of immunotherapy - ...
Anthem Blue Cross and Blue Shield in New York and Memorial Sloan Kettering Cancer Center (MSK) announced today that the organizations have reached a new multi-year agreement providing Anthem members ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback